Ropes & Gray represented Audax Private Equity in the sale of CorEvitas, LLC to Thermo Fisher Scientific Inc., which has been named a 2024 Mid-Market Deal of the Year by Mergers & Acquisitions. The deal team was led by private equity partner Ken Chow, finance partner Mike Lee, employment partner Megan Bisk, executive compensation & employee benefits partner Jenny Rikoski, litigation & enforcement partners Samer Musallam and Thomas Brown, healthcare partner Michael Lampert, and environmental partner Peter Alpert.
“These exceptional transactions transcended a variety of market headwinds faced by dealmakers in the last year,” Mergers & Acquisitions wrote of the 2024 mid-market deals that received recognition.
CorEvitas is a provider of regulatory-grade, real world evidence for approved medical treatments and therapies. Based in Boston and San Francisco, Audax Private Equity is a leading middle market investment firm with approximately $16 billion of assets under management.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.